Latest research news

Get up-to-date with everything MS research.

Our research community keep us updated with all the latest news. You can also head over to our research blog for a more in depth look at developments.

Add bookmark

Latest research news

Study shows high-dose biotin doesn’t slow MS progression

Results released last week unfortunately show no effect of high-dose biotin on progressive MS.

Could a wearable robot help you exercise?

Virtual reality, wearable robots and magnetic brain stimulation. Technology is at the forefront of 13 new research projects announced this month.

Predicting who'll develop secondary progressive MS

New research has shown measures taken one year after diagnosis can predict how MS develops thirty years later.

Stop MS: we launch our biggest fundraising appeal

Today we’ve publicly launched our biggest fundraising appeal ever. Our Stop MS Appeal aims to raise £100 million over a ten year period to accelerate new research and stop MS.

Diabetes drug metformin promotes myelin repair in rats

Research we funded has shown that alternate day fasting - and the diabetes drug metformin - can improve myelin repair in rats.

First results of new stem cell therapy trial announced

While HSCT has been making headlines for a few years, a new international trial has tested a different kind of stem cell therapy, called MSCT.

Scientists reverse stem cell ageing in rats

As our bodies age, muscles and joints can become stiff, making everyday movements more difficult. New research, which we've part-funded, has shown the same is true in our brains.

MRI scans can help predict MS progression

New research published today has found early MRI scans can be used to predict long-term outcomes for people with relapsing MS.

New insights into the role of vitamin D in our immune system

New research shows that vitamin D is associated with a reduced immune response – which has implications for autoimmune conditions like MS.

People with progressive MS have 'older' neural stem cells

Researchers have found the neural stem cells of people with primary progressive MS appear to be older than they are.

New research shows DMTs can extend life expectancy for people with MS

A long-term study has shown that beta-interferon drugs can improve survival rates.

Research shows hot chocolate could help reduce fatigue

Our research shows Flavonoids found in cocoa could help reduce fatigue in people with relapsing MS.

New research into why pregnancy protects women against the effects of MS

We’re proud to be funding Professor Lars Fugger from the University of Oxford to investigate why women often have fewer MS symptoms when pregnant.

Study explores DMT prescribing across the UK

As part of a study we commissioned, researchers have interviewed neurologists and MS nurses from across the UK to find out more about their views and experiences of prescribing DMTs.

Important differences in myelin making cells discovered

Researchers have shown for the first time that not all our myelin-making cells are the same. They also found that the mix of these cells was different in people with MS.

Smoking and low Vitamin D both worsen prognosis for people with CIS

Two new studies show that smoking and low vitamin D increase the risk of disability progression and declining cognitive function for people with clinically isolated syndrome (CIS).

First multi-drug clinical trial in MS successfully completed

The results of the MS SMART trial ruled out 3 repurposed drugs for the treatment of progressive MS.

MS-STAT2 trial for secondary progressive MS begins UK-wide recruitment

The landmark phase 3 trial for secondary progressive MS, co-funded by the MS Society, will involve 1,180 people across the UK.

NICE says initial no to ocrelizumab for primary progressive MS

National Institute for Health and Care Excellence (NICE) provisionally decide not to recommend ocrelizumab for people with primary progressive MS on the NHS. This is the first stage of their review into this new MS treatment.

New research shows excess myelin goes to the wrong part of nerve

Researchers at the MS Society Edinburgh Centre for MS Research have found that extra myelin can be sent to the wrong part of the nerve – an important insight for MS treatments.

Join the Research Network

Our Research Network make sure all the research we fund reflects the needs and interests of people living with MS. And they help us talk about it in a way that’s accessible to everyone.

Anyone who lives with MS or cares for someone who does can get involved. It doesn't matter where in the UK you live or how much research experience you have.

Find out more and join the Research Network

Latest research news

Latest research news

Study shows high-dose biotin doesn’t slow MS progression

Could a wearable robot help you exercise?

Predicting who'll develop secondary progressive MS

Stop MS: we launch our biggest fundraising appeal

Diabetes drug metformin promotes myelin repair in rats

First results of new stem cell therapy trial announced

Scientists reverse stem cell ageing in rats

MRI scans can help predict MS progression

New insights into the role of vitamin D in our immune system

People with progressive MS have 'older' neural stem cells

New research shows DMTs can extend life expectancy for people with MS

Research shows hot chocolate could help reduce fatigue

New research into why pregnancy protects women against the effects of MS

Study explores DMT prescribing across the UK

Important differences in myelin making cells discovered

Smoking and low Vitamin D both worsen prognosis for people with CIS

First multi-drug clinical trial in MS successfully completed

MS-STAT2 trial for secondary progressive MS begins UK-wide recruitment

NICE says initial no to ocrelizumab for primary progressive MS

New research shows excess myelin goes to the wrong part of nerve

You may also be interested in

A shared goal to stop MS - new funding for research Centres of Excellence

Policy on use of animals in research

How we decide what to fund

Join the Research Network